
ESCP on Personalised Healthcare
bioXclusters plus
Overview
Type of partnership

Target countries
Partnership duration (months)
Number of partners
Number of SMEs involved
Status
Summary and objectives
The bioXclusters+ alliance, supported from 2016 to 2018, gathers 4 European Life Sciences / health clusters: Biocat (Catalonia), BioM (Bavaria), BioPmed (Piedmont), Lyonbiopole (Auvergne Rhone-Alpes). It aims to address the next-decade European challenges related to healthcare and SMEs growth, thanks to a common vision of personalised healthcare as the paradigm for future global healthcare solutions. To address this new paradigm, the bioXclusters+ partnership intends to be the most competitive European meta-cluster initiative in personalised healthcare, delivering at global level cutting edge solutions through its innovation ecosystem and offering an entry point for global players to Europe. In this regard, the consortium internationalisation strategy plan to focus their activities on three countries already explored (US, China and Brazil) but also on additional markets such as Japan. The approach consists in confirming its position at European and international scene in gaining visibility inside and outside Europe; reinforcing trustful relations with target countries building Gateways; deploy common internationalisation tools and tailored supported to European SMEs based on the mutual competence knowledge and long term relationship developed within the alliance. Furthermore the alliance will focus their action on addressing the challenges related to the global healthcare sector, such as the inclusion of technologies such as big data, micro and nanotechnologies, ICT for the development of systemic and practical solutions addressing the industry competitiveness and the patients' needs. This is the reason why collaboration with other key players (such as other ESCPs and other EU initiatives) in the sector mentioned above will be deploy.
Previous achievements
Partnership other activities
- Meta-cluster marketing and communication Shaping
- Reinforcing and building gateways to third countries including a cross-sectoral dimension
- Tailoring tools and services for SMEs (information package, missions abroad, B2B meetings...)
- Monitoring activities and indicators
Results expected
Signature of MoUs and gateways agreements with third countries
Organisation of C2C and B2B meetings
Organisation of inbound and outbound missions
Increase of collaborations with SMEs and external partners (technological and commercial agreements)
Sectorial and industrial focus
Sectoral industries
Cross-sectoral industries
Industrial Alliances and Ecosystems
Technology fields
S3 EU priority areas
Areas of specialisation not covered above
Development of Healthcare solutions and products (innovative targeted therapies, diagnostic tools and solutions, e-health solutions...)
Partnership composition
Profile name | Location | Project coordinator | |
---|---|---|---|
Biocat (Bioregion of Catalonia) |
Spain
|
||
LYONBIOPOLE |
France
|
||
Biocat (Bioregion of Catalonia) |
Spain
|
||
bioPmed / Bioindustry Park |
Italy
|
||
BioM Biotech Cluster Development GmbH |
Germany
|
Other linked key partners or networks
Profile name | Location | Network type | |
---|---|---|---|
CEBR |
Belgium
|
||
BioSA and Health Industries South Australia |
Australia
|
||
Osaka Bio Headquarters |
Japan
|
||
Chuncheon Bioindustry Foundation |
South Korea
|
||
Fenglin Group |
China
|
||
ToHealth! |
Canada
|
||
Wistar Institute |
United States
|
Upcoming events
Monday | Tuesday | Wednesday | Thursday | Friday | Saturday | Sunday |
---|---|---|---|---|---|---|
30
|
31
|
1
|
2
|
3
|
4
|
5
|
|
|
|||||
6
|
7
|
8
|
9
|
10
|
11
|
12
|
13
|
14
|
15
|
16
|
17
|
18
|
19
|
20
|
21
|
22
|
23
|
24
|
25
|
26
|
27
|
28
|
29
|
30
|
1
|
2
|
3
|
|
|
|
Latest news and documents
bioXclusters plus 2nd newsletter
bioXclusters plus' newsletters
bioXclusters alliance flying to BIO Intl. Convention, Boston (from June 4 to 7, 2018)
Submitted best practices
There is no uploaded content...